tiprankstipranks
Trending News
More News >
Enliven Therapeutics (ELVN)
NASDAQ:ELVN
US Market
Advertisement

Enliven Therapeutics (ELVN) Technical Analysis

Compare
304 Followers

Technical Sentiment

Overall Consensus
Neutral
9Bullish
5Neutral
8Bearish
Technical Analysis Consensus
Sell
2Bullish
5Neutral
3Bearish
Moving Average Consensus
Buy
7Bullish
0Neutral
5Bearish
Enliven Therapeutics’s (ELVN) Moving Averages Convergence Divergence (MACD) indicator is <0.01, suggesting Enliven Therapeutics is a Sell.
Enliven Therapeutics’s (ELVN) 20-Day exponential moving average is 19.71, while Enliven Therapeutics’s (ELVN) share price is $19.92, making it a Buy.
Enliven Therapeutics’s (ELVN) 50-Day exponential moving average is 19.84, while Enliven Therapeutics’s (ELVN) share price is $19.92, making it a Buy.

Enliven Therapeutics (ELVN) Pivot Points

Oct 04, 2025, 08:00 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
18.61
19.19
19.50
20.08
20.39
20.97
21.28
Fibonacci
19.19
19.53
19.74
20.08
20.42
20.63
20.97
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Enliven Therapeutics (ELVN) Moving Averages

Oct 04, 2025, 08:00 AM
Period
Simple
Exponential
MA5
20.10Sell
19.91Buy
MA10
19.64Buy
19.77Buy
MA20
19.56Buy
19.71Buy
MA50
19.69Buy
19.84Buy
MA100
19.97Sell
20.10Sell
MA200
20.35Sell
21.12Sell
Enliven Therapeutics’s (ELVN) 10-Day exponential moving average is 19.77, while Enliven Therapeutics’s (ELVN) share price is $19.92, making it a Buy.
Enliven Therapeutics’s (ELVN) 100-Day exponential moving average is 20.10, while Enliven Therapeutics’s (ELVN) share price is $19.92, making it a Sell.
Enliven Therapeutics’s (ELVN) stock price is $19.92 and Enliven Therapeutics’s (ELVN) 50-day simple moving average is 19.69, creating a Buy signal.
Enliven Therapeutics’s (ELVN) stock price is $19.92 and Enliven Therapeutics’s (ELVN) 100-day simple moving average is 19.97, creating a Sell signal.
Enliven Therapeutics’s (ELVN) stock price is $19.92 and Enliven Therapeutics’s (ELVN) 200-day simple moving average is 20.35, creating a Sell signal.

Enliven Therapeutics (ELVN) Technical Indicators

Oct 04, 2025, 08:00 AM
Name
Value
Implied Action
RSI (14)
51.32
Neutral
STOCH (9,6)
68.32
Neutral
STOCHRSI (14)
71.28
Neutral
MACD (12,26)
<0.01
Sell
ADX (14)
13.38
Buy
Williams %R
-33.91
Buy
CCI (14)
21.05
Neutral
ATR (14)
1.13
-
Ultimate Oscillator
50.51
Neutral
ROC
-0.20
Sell
Enliven Therapeutics’s (ELVN) Relative Strength Index (RSI) is 51.32, creating a Neutral signal.
Enliven Therapeutics’s (ELVN) Trend Strength Indicator (ADX) is 13.38, creating a Buy signal.
Enliven Therapeutics’s (ELVN) Commodity Channel Index (CCI) is 21.05, creating a Neutral signal.
Enliven Therapeutics’s (ELVN) Price Rate of Change (ROC) is -0.20, creating a Sell signal.

FAQ

Is ELVN a Buy, Hold, or Sell?
Based on ELVN’s technical indicators, ELVN is a Hold.
    What is ELVN’s RSI (14)?
    ELVN’s RSI (14) is 51.32, which suggests ELVN is a Neutral.
      What is ELVN’s MACD?
      ELVN’s MACD is <0.01, which suggests ELVN is a Sell.
        What is ELVN’s 5-day moving average?
        ELVN’s 5-day moving average is 20.10, which suggests ELVN is a Sell.
          What is ELVN’s 20-day moving average?
          ELVN 20-day moving average is 19.56, which suggests ELVN is a Buy.
            What is ELVN’s 50-day moving average?
            ELVN’s 50-day moving average is 19.69, which suggests ELVN is a Buy.
              What is ELVN’s 200-day moving average?
              ELVN’s 200-day moving average is 20.35, which suggests ELVN is a Sell.
                What is ELVN’s Williams % R (14)?
                ELVN’s Williams % R (14) is -33.91, which suggests ELVN is a Buy.
                  What is ELVN’s CCI (14)?
                  ELVN’s CCI (14) is 21.05, which suggests ELVN is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis